Effect of Tablet Sildenafil in Intrauterine growth restriction

Role of Sildenafil in Intrauterine Growth Restriction - A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064340

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O352- Maternal care for (suspected) hereditary disease in fetus Health Condition 2: O098- Supervision of other high risk pregnancies

Interventions

Intervention1: Randomised Controlled Trial: 60 Adult patients attending in Department of Gynaecology, RMCH. Study Design: Randomized Controlled Trial. Study location: Department of Gynaecology, Rohilk

Eligibility

Inclusion criteria

Inclusion criteria: 1. From 28-37 weeks POG. 2. singleton pregnancy. 3. normal fetal Doppler study. 4. uncomplicated intra uterine growth restriction

Exclusion criteria

Exclusion criteria: 1. fetal malformation 2. severe preeclampsia 3. maternal coexisting complications

Design outcomes

Primary

Measure	Time frame
1-Symphysio fundal height match period of gestation +/- 2 weeks. 2-AFI more than 5 3-fetal weight above10th percentile for gestational ageTimepoint: from 28 -37 weeks POG for one year	—

Secondary

Measure	Time frame
duration of hospital stayTimepoint: at discharge	—

Countries

India

Contacts

Public ContactDr. Pragya Mishra

Rohilkhand Medical College and Hospital, Pilibhit Bypass Road, Bareilly Uttar Pradesh,India

pragya_mshr@yahoo.co.in8435333777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026